Lucarini, L., Durante, M., Lanzi, C., Pini, A., Boccalini, G., Calosi, L., . . . Mannaioni, G. (2016). HYDAMTIQ, a selective PARP‐1 inhibitor, improves bleomycin‐induced lung fibrosis by dampening the TGF‐β/SMAD signalling pathway. J Cell Mol Med.

Lucarini, Laura, Mariaconcetta Durante, Cecilia Lanzi, Alessandro Pini, Giulia Boccalini, Laura Calosi, Flavio Moroni, Emanuela Masini, ja Guido Mannaioni. "HYDAMTIQ, a Selective PARP‐1 Inhibitor, Improves Bleomycin‐induced Lung Fibrosis By Dampening the TGF‐β/SMAD Signalling Pathway." J Cell Mol Med 2016.

Lucarini, Laura, et al. "HYDAMTIQ, a Selective PARP‐1 Inhibitor, Improves Bleomycin‐induced Lung Fibrosis By Dampening the TGF‐β/SMAD Signalling Pathway." J Cell Mol Med 2016.